Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Long-term follow-up data presented from phase IIa study of KD-025 in cGvHD

Dec. 31, 2019

China NMPA approves Sinovac's varicella vaccine

Dec. 30, 2019

Transplantation with MGTA-456 results in complete engraftment and rapid recovery

Dec. 30, 2019

FDA approves Ervebo for prevention of Ebola virus disease

Dec. 20, 2019

New autoinflammatory disease linked to RIPK1 gene variants

Dec. 19, 2019

New human autoinflammatory disease discovered

Dec. 18, 2019

Soligenix initiates phase Ic study of RiVax

Dec. 13, 2019

CYT-0853 demonstrates promising activity in models of autoimmune disease

Dec. 12, 2019

With reduced toxicity, can HSCT make it to Hall of Fame?

Dec. 10, 2019

CD3/CD7-IT causes clinical remission and rapid immune reconstitution in SR-aGvHD: phase I/II results

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...